Founder, Bridle Path Investments

Ruvin Orbach is the Founder of Bridle Path Investments, where he supports emerging companies through strategic investment, company development, capital formation, and partnership building. Drawing on decades of experience across biotechnology, healthcare, diagnostics, regenerative medicine, and technology, he helps promising ventures strengthen their commercial foundations and move innovative ideas toward broader market and patient impact.

​

As Founder, Ruvin guides Bridle Path Investments’ strategic direction and evaluates opportunities with the potential to address significant unmet needs. His work includes supporting leadership teams, developing investor and industry relationships, identifying strategic partners, and helping companies secure the resources required for sustainable growth.

​

Ruvin brings extensive experience building companies, raising capital, forming strategic alliances, and advancing early-stage ventures. His commercial perspective is grounded in an understanding of how scientific innovation, experienced leadership, disciplined execution, and access to capital must work together to create long-term value.

​

In addition to Bridle Path Investments, Ruvin is the Founder of CellxLife, a biotechnology company focused on advancing innovative cancer therapies. He also supports healthcare innovation through WonderBank Holdings and Orbach Family Office, working with emerging companies on investment, company formation, and strategic development.